151 related articles for article (PubMed ID: 34544982)
1. Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging.
Young BD; Moreland H; Oatmen KE; Freeburg LA; Shahab Z; Herzog E; Miller EJ; Spinale FG
Int Heart J; 2021 Sep; 62(5):1096-1105. PubMed ID: 34544982
[TBL] [Abstract][Full Text] [Related]
2. A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis.
Kiko T; Yoshihisa A; Kanno Y; Yokokawa T; Abe S; Miyata-Tatsumi M; Misaka T; Oikawa M; Kobayashi A; Ishida T; Takeishi Y
Int Heart J; 2018 Sep; 59(5):996-1001. PubMed ID: 30101857
[TBL] [Abstract][Full Text] [Related]
3. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous study of matrix metalloproteinases, proinflammatory cytokines, and soluble cytokine receptors in the tears of noninfectious corneal ulcer patients.
Sakimoto T; Ohnishi T; Ishimori A
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1451-6. PubMed ID: 25005620
[TBL] [Abstract][Full Text] [Related]
5. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
Ito K; Okazaki O; Morooka M; Kubota K; Minamimoto R; Hiroe M
Intern Med; 2014; 53(18):2041-9. PubMed ID: 25224185
[TBL] [Abstract][Full Text] [Related]
6. (18)F-Fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in Takayasu's arteritis.
Arraes AE; de Souza AW; Mariz HA; Silva NP; Torres IC; Pinto PN; Lima EN; Sato EI
Rev Bras Reumatol Engl Ed; 2016; 56(4):299-308. PubMed ID: 27476622
[TBL] [Abstract][Full Text] [Related]
7. Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis.
Ning N; Guo HH; Iagaru A; Mittra E; Fowler M; Witteles R
J Card Fail; 2019 Apr; 25(4):307-311. PubMed ID: 30825644
[TBL] [Abstract][Full Text] [Related]
8. Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
Churchill R; Sykora D; Castrichini M; Arment C; Myasoedova E; Elwazir M; Bois J; Young K; Rosenbaum A
Am J Cardiol; 2023 Oct; 205():20-27. PubMed ID: 37579656
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
[TBL] [Abstract][Full Text] [Related]
10. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
Nery PB; Beanlands RS; Nair GM; Green M; Yang J; McArdle BA; Davis D; Ohira H; Gollob MH; Leung E; Healey JS; Birnie DH
J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
[TBL] [Abstract][Full Text] [Related]
11. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.
Ahmadian A; Brogan A; Berman J; Sverdlov AL; Mercier G; Mazzini M; Govender P; Ruberg FL; Miller EJ
J Nucl Cardiol; 2014 Oct; 21(5):925-39. PubMed ID: 24879453
[TBL] [Abstract][Full Text] [Related]
12. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.
Keijsers RG; Verzijlbergen FJ; Oyen WJ; van den Bosch JM; Ruven HJ; van Velzen-Blad H; Grutters JC
Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1131-7. PubMed ID: 19259660
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.
Mostard RL; Vöö S; van Kroonenburgh MJ; Verschakelen JA; Wijnen PA; Nelemans PJ; Erckens RJ; Drent M
Respir Med; 2011 Dec; 105(12):1917-24. PubMed ID: 21899998
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Yokoyama R; Miyagawa M; Okayama H; Inoue T; Miki H; Ogimoto A; Higaki J; Mochizuki T
Int J Cardiol; 2015 Sep; 195():180-7. PubMed ID: 26043154
[TBL] [Abstract][Full Text] [Related]
17. The Utility of Whole Body
Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience.
Gilotra NA; Wand AL; Pillarisetty A; Devraj M; Pavlovic N; Ahmed S; Saad E; Solnes L; Garcia C; Okada DR; Constantinescu F; Mohammed SF; Griffin JM; Kasper EK; Chen ES; Sheikh FH
J Card Fail; 2021 Jan; 27(1):83-91. PubMed ID: 32889044
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis.
Divakaran S; Stewart GC; Lakdawala NK; Padera RF; Zhou W; Desai AS; Givertz MM; Mehra MR; Kwong RY; Hedgire SS; Ghoshhajra BB; Taqueti VR; Skali H; Dorbala S; Blankstein R; Di Carli MF
Circ Cardiovasc Imaging; 2019 Jun; 12(6):e008975. PubMed ID: 31177817
[TBL] [Abstract][Full Text] [Related]
20. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
